Treatment With Ribavirin for Patients With Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn whether oral Ribavirin is safe and effective in
treating patients with metastatic breast cancer, that have high levels of eIF4E.